News and Events
Recent News Releases
First study in humans shows promise for preventing graft-vs.-host disease following bone marrow transplant
The study, the first to test this treatment in people, combined the drug vorinostat with standard medications given after transplant, resulting in 22 percent of patients developing graft-vs.-host disease compared to 42 percent of patients who typically develop this condition with standard medications alone.
Researchers unravel mystery of how leukemia-causing mutations enable pre-leukemic stem cells to outperform their healthy counterparts
Researchers at the Children's Medical Center Research Institute at UT Southwestern, the University of California at San Francisco and the University of Michigan Comprehensive Cancer Center have solved a mystery that has stumped scientists for years, discovering how leukemia-causing mutations enable pre-leukemic stem cells to outperform their healthy counterparts.
Wicha to focus on his research after 27 years at the helm
"It has been my honor and privilege to lead the University of Michigan Comprehensive Cancer Center over all of these years, as it has developed into one of the leading cancer centers in the nation," Wicha says.
While serving as director, Wicha has continued to maintain his laboratory research and clinical practice seeing patients with breast cancer. In 2003, he was part of the team that first identified breast cancer stem cells.
Whether or not low-risk women aged 30-65 get tested for root cause of cervical cancer depends on doctor; variations among clinics, physician status and gender
Female family physicians are twice as likely to order the HPV test (in addition to screening for cervical cancer through pap smears) for low-risk women aged 30-65 than their male counterparts, according to the findings published in the Journal of the American Board of Family Medicine.
- 12.11.12 Capturing circulating cancer cells could provide insights into how disease spreads
- 12.11.12 Anti-aging gene identified as tumor suppressor in mice, research finds
- 12.09.12 New drug cuts risk of deadly transplant side effect in half
- 12.07.12 Cognitive problems may be present before chemotherapy in women with breast cancer
- 12.05.12 Ponatinib acts against the most resistant types of chronic myeloid leukemia
- 12.04.12 Drug shows promise in prostate cancer spread to bone
- 12.04.12 U-M study finds overuse of diagnostic imaging prevalent in patients with early stage breast cancer
- 11.27.12 Most women who have double mastectomy don't need it
- 11.12.12 Spread of human melanoma cells in mice correlates with clinical outcomes in patients, study finds
- 10.29.12 U-M Cancer Center gets $28.4 million grant from NCI
- 10.17.12 SARC receives $11.5 million award for collaborative translational sarcoma research
- 10.08.12 U-M startup Compendia Bioscience acquired by Life Technologies
- 10.08.12 The University of Michigan's Breast Oncology Program to Benefit from QVC Presents 'FFANY Shoes on Sale'
- 10.01.12 Smoking, heavy drinking linked to earlier onset of pancreatic cancer